Merantix Healthcare wins breast AI clearance

By staff writers

October 31, 2019 -- Merantix Healthcare of Berlin has received the CE Mark for its artificial intelligence (AI) software for breast cancer screening.

The company's Vara software filters out healthy mammography images, reducing radiologists' workload. Vara is thought to be Germany's first approved AI software for cancer screening, and it is being installed at facilities in five European countries, according to the firm.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking